Peptide API Batch Record Review: A Guide for Procurement and QA

A peptide API batch record review for procurement and QA is more than a paperwork exercise. The batch record shows how a specific lot was actually made, which steps were performed, and whether in-process controls were met. For buyers, it is one of the few windows into routine manufacturing practice. Reviewing records before qualification and periodically during supply helps confirm that the process described in supplier documents is the process being run. The review should follow an agreed checklist so results are comparable across lots.

Start with the structure of the record. A complete batch record should identify the product, lot number, manufacturing date, equipment used, and personnel responsible for each step. It should reference the master batch record version and any approved deviations. Procurement teams should confirm that the record is legible, complete, and traceable to the certificate of analysis for the same lot. Missing pages, unexplained corrections, or unsigned steps are signals to ask questions before proceeding.

Process steps deserve close attention. Reviewers should follow the synthetic route through coupling, deprotection, cleavage, purification, and drying, checking that quantities, temperatures, and times are recorded against defined ranges. In-process controls such as reaction completion, pH, and conductivity should have actual measured values, not just checkmarks. QA should look for evidence that out-of-range results triggered investigation and documented disposition. A record that shows only conforming values without supporting data may be incomplete.

Deviation and investigation sections are often the most informative. A lot with no deviations is not automatically better than one with well-documented and resolved issues. Reviewers should check that deviations are described clearly, that root cause analysis is proportionate, and that corrective actions were completed. Procurement teams should ask how deviation trends are monitored across lots. Repeated minor deviations in the same step can indicate a process that is not fully controlled, even if each lot was released.

Material and component traceability is another key area. The record should identify raw materials, resins, reagents, and solvents used, with lot numbers that allow tracing to supplier certificates. For custom peptides, this includes any special building blocks or modified amino acids. QA should verify that materials met incoming specifications and that any substitutions were approved. Traceability gaps make it difficult to investigate future quality issues and can complicate regulatory review.